Anika Therapeutics Inc.

NASDAQ: ANIK · Real-Time Price · USD
8.90
0.26 (3.01%)
At close: Aug 15, 2025, 12:20 PM

Anika Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-56.38M -82.67M -14.86M 4.13M
Depreciation & Amortization
8.12M 14.22M 14.49M 14.32M
Stock-Based Compensation
13.13M 15.24M 14.31M 11.09M
Other Working Capital
-4.53M 589K -1.28M -783K
Other Non-Cash Items
52.76M 69.87M 7.56M -4.66M
Deferred Income Tax
260K -6.33M -5.27M -1.77M
Change in Working Capital
-13.09M -12.12M -11.82M -14.72M
Operating Cash Flow
5.4M -1.79M 4.41M 8.4M
Capital Expenditures
-7.73M -5.43M -7.49M -5.14M
Cash Acquisitions
n/a n/a n/a -476K
Purchase of Investments
n/a n/a n/a -2.02M
Sales Maturities Of Investments
n/a n/a n/a 2.5M
Other Investing Acitivies
-600K n/a -7.49M 2.02M
Investing Cash Flow
-8.33M -5.43M -7.49M -3.12M
Debt Repayment
n/a n/a -284K -201K
Common Stock Repurchased
-10.91M -5M -934K -486K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1.81M -1.32M -4.57M -6.58M
Financial Cash Flow
-12.73M -6.32M -4.85M -6.78M
Net Cash Flow
-15.71M -13.46M -8.06M -1.43M
Free Cash Flow
-2.33M -7.21M -3.08M 3.25M